Keywords: colorectal cancer, CAR T cells, immunotherapies, tumor microenvironement, tumor mutational burden, clinical dataCitation: Ghazi B, El Ghanmi A, Kandoussi S, Ghouzlani A and Badou A (2022) CAR T-cells for colorectal cancer immunotherapy: Ready to go? Front. Immunol. 13:978195. doi: 10.3389/fimmu.2022.978195Received: 25 June 2022; Accepted: 14 October 2022;Published: 15 November 2022.Edited by:Lynn Morris, National Institute of Communicable Diseases (NICD), South Africa